Company / Interest Expense per Share
Sarepta Therapeutics Interest Expense per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.02
FY2025
5-year range
-$0.25 / $0.80
FY2021-FY2025
Trend
+110.0%
vs FY2024
Sector context
#37 of 43
Health Care
What the data says
Sarepta Therapeutics's interest expense per share of $0.02 is lower than 86% of companies in the Health Care sector (FY2025). Interest Expense per Share has fluctuated over the past 10 years, ranging from $-0.25 in FY2023 to $0.80 in FY2021.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of -46.5%.
Increased from $-0.25 to $0.02 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -69.5%
- 5-Year CAGR
- -46.5%
- 10-Year CAGR
- -
Sector benchmark
-99.9% below sector average
Key checks
Key Insights
- In FY2025, interest expense per share increased 110.0% year-over-year.
- Ranks #37 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2021.
- Lowest interest expense per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | +110.0% |
| FY2024 | -$0.20 | +21.6% |
| FY2023 | -$0.25 | -136.4% |
| FY2022 | $0.69 | -14.0% |
| FY2021 | $0.80 | +78.5% |
| FY2020 | $0.45 | +449.3% |
| FY2019 | $0.08 | -84.3% |
| FY2018 | $0.52 | +391.1% |
| FY2017 | $0.11 | +155.5% |
| FY2016 | $0.04 | +28.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026